| Website | venturefund.novar... |
| Phone | +41 61 324 32 67 |
| simone.forrer@nov... | |
| Employees | |
| Description | venture capital fund |
Investing in innovative life sciences concepts for patient benefit creating attractive returns for entrepreneurs and investors.
| Company | Date | Round | Size | Participants |
| F2G | 9/12 | Venture Round | $30M | 6 |
| Aerpio Therapeutics | 8/12 | Series A | $27M | 6 |
| Akebia Therapeutics | 1/12 | Series B | $4.1M | 7 |
| Cylene Pharmaceuticals | 9/10 | Series D | $12M | 6 |
| Pulmatrix | 11/09 | Series B | $30.2M | 4 |
| ESBATech | 8/08 | Series B | $22M | 7 |
| Ascent Therapeutics | 11/07 | Series A | $8M | 3 |
| Phenomix | 3/07 | Series C | $55M | 10 |
| Trellis Bioscience | 2/07 | Series B | $10M | 4 |
| PTC Therapeutics | 11/05 | Venture Round | $26.6M | 9 |